← Back to patent-cliff list
CAS 14062-25-0
ethyl 2-(4-bromophenyl)acetate
Codes：EVOCA-007
Application context (from source-drug indications)
继发性甲状旁腺功能亢进症依伏卡塞甲状旁腺癌依伏卡塞原发性甲状旁腺功能亢进症依伏卡塞甲状旁腺功能亢进症依伏卡塞
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| 依伏卡塞Evocalcet | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
(R)-tert-butyl 3-hydroxypyrrolidine-1-carboxylate→tert-butyl (R)-3-(((2-nitrophenyl)sulfonyl)oxy)pyrrolidine-1-carboxylate→(R)-1-(naphthalen-1-yl)ethan-1-amine→tert-butyl (S)-3-(((R)-1-(naphthalen-1-yl)ethyl)amino)pyrrolidine-1-carboxylate→propan-2-ol compound with (S)-N-((R)-1-(naphthalen-1-yl)ethyl)pyrrolidin-3-amine (1:1) hydrochloride→(S)-N-((R)-1-(naphthalen-1-yl)ethyl)pyrrolidin-3-amine→ethyl 2-(4-bromophenyl)acetate→ethyl 2-(4-((S)-3-(((R)-1-(naphthalen-1-yl)ethyl)amino)pyrrolidin-1-yl)phenyl)acetate hydrochloride→2-(4-((S)-3-(((R)-1-(naphthalen-1-yl)ethyl)amino)pyrrolidin-1-yl)phenyl)acetic acid
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.